SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (504)8/9/2002 10:37:49 AM
From: Jibacoa  Read Replies (2) | Respond to of 544
 
DNDN Is having an up-move today in spite of announcing this morning that Provenge didn't show statistical significant results on its Phase III trial for prostate Ca.<g>

Of course the stock has been selling at 0.86 of book and below its cash/share.<g>( reportedly it has $2.85 in cash/share.)

The institutions that hold more than 100% of the float had been buying lately and the insiders hold more than 60%.<g>

siliconinvestor.com

siliconinvestor.com

Bernard



To: Jibacoa who wrote (504)8/9/2002 2:21:28 PM
From: Jibacoa  Read Replies (1) | Respond to of 544
 
ALKS Has continued doing well.<g>

It is now up 28.11% for the day and volume is going to be over 3 million.(It is going to be close to 3x its daily average.<g)

siliconinvestor.com

As I mentioned it seems it will close some of its July 1st down-gap.<g>

siliconinvestor.com

At any rate, 28% is not a bad gain for a day these days.<g>

Bernard